PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2007 2008 2009
08.P0107 SCMS-Supplies for Early Infant Diagnosis
2007 accomplishments
Procurement of laboratory supplies, reagents, and equipment is done through MOH's Central Medical
Stores (CMS). Gaps in the system result in delayed receipt of the laboratory equipment, reagents, and
supplies at the end point. In FY2006, the nationwide roll-out of early infant diagnosis began and continued
through FY 2007 with USG support.
2008 Plans
The USG will continue this support to the program by procuring laboratory supplies, reagents, and
equipment for the PMTCT program. Commodities will be procured in accordance with the GOB national
protocols, and USG rules and regulations. About 5,000 infant diagnostic DNA PCR kits will be purchased to
support the implementation of EID nationally as well as equip the second laboratory in Francistown.
These activities will be supported through the in-country SCMS team.
08.P0106 SCMS - Infant Formula Supply Logistics
The Botswana national PMTCT program provides all babies born to HIV-positive mothers with free infant
formula until they are 12 months old. Tins of powdered formula are provided and picked up by mothers at
public health clinics. During FY 2007, 13,000 babies received free formula. The program distributes infant
formula to three warehouses, which in turn distribute formula as it is ordered by districts, which then
distribute to clinics. At the national level, infant formula shortages occurred in 2005 and 2006 and
emergency formula supplies were purchased by PEPFAR. Causes of the shortages include difficulties with
government procurement processes and regional supply shortages. There is no infant formula manufacturer
in Botswana, and formula is usually procured from South Africa via local contractors (though bids from other
manufacturers are accepted). The national PMTCT program has no formal training in supply management,
no contingency plans for purchasing substitute foods for infants and no plan for formula rationing in times of
shortage. Improvements in formula supply chain difficulties are a high priority for the national program.
2007 Accomplishments
An assessment completed by UNICEF and CDC (with SCMS) highlighted the near lack of systems for
forecasting, procurement planning, storage, distribution and general stock management of the product at
the three warehouses and the clinics where it is given out. The new system developed to meet this need
requires maintenance and quality assurance. In April 2007, SCMS began supporting the PMTCT Unit in
procurement planning, process management, and forecasting of infant formula requirements and providing
technical support for designing a more viable and sustainable supply system.
SCMS will conduct the following activities in FY2008: 1) Design an operational supply and distribution
management system using a robust Logistic Information Management System (LMIS). 2) Assist the PMTCT
Unit in procurement management for bid documents preparation, evaluation criteria and definition of
deliverables for effective supply contract performance management. 3) Train supply officers in inventory
and distribution management, demand management and forecasting, commodity tracking. 4) SCMS
logistics experts will provide continuing on-site mentoring support to entrench tools and standard operating
procedures introduced. All of these will address shortfalls identified in the assessment.
08.C0708: SCMS - Strengthening Lab Capacity
2007 Achievements
Prefabricated laboratories and additional laboratory personnel were provided by another stakeholder to
improve the TB diagnostic capacity in the country. FY2007 funds (including Plus Up funds) were used to
provide laboratory supplies, equipment and improve laboratory space for TB in the primary and district
hospital laboratories, the construction of the second culture and DST laboratory in Francistown and for the
reconstruction of the NTRL isolation room. The support improved quality control and quality assurance
systems in the laboratory network, resulting in enrolment of the reference laboratory for accreditation and
the commencement of the national drug resistance survey in July 2007.
FY2008 funds to SCMS will serve to procure equipment and laboratory supplies for TB culture and DST at
the NTRL, and to expand these services to the NRH laboratory. FY08 PEPFAR funds will support the
procurement of additional equipment and supplies to the new laboratories, including laboratories under the
MLG. The funds will also help to improve the transport of sputum and results from clinics to the laboratories
and the laboratories to clinics and hospitals.
08.T1002: ARV Drugs: SCMS
The GOB through its MASA program currently provides antiretroviral treatment to 90,478 patients at 32
hospitals and 30 satellite clinics. It is projected that this number will grow to 104,900 patients by September
2008. The number of satellite clinics will increase to 80 by March 2008 and 128 by March 2009.
HIV/AIDS commodities used in prevention, care and treatment are procured and distributed by CMS which
is charged with managing the entire supply chain for the country. CMS receives direct support from
PEPFAR for commodity procurement and this contribution is estimated to be equivalent to about 15% of the
total ARV procurement cost in the country. CMS has also been supported to train and hire staff to support
ART scale-up and to increase procurement of pediatric formulations.
Currently most ARVs used in the country are innovator brands as donations from multinational companies
(Merck) and the rest are procured with government funds. The government receives USG support through
DRU to strengthen systems for generic ARV registration in order to lower cost of ARVs. NDQCL received
support to augment their technology and skills capacity for quality testing of generic ARVs. The Clinton
Foundation has promised to donate pediatric ARVs for FY2007 and FY2008. SCMS proposes to continue
supporting all these organizations in FY2008 to augment capacities needed to build sustainable HIV/AIDS
supply chains in Botswana. SCMS will work as a partner to these organizations within the existing systems
and not develop any parallel systems.
This proposes activity has several components. One component provides technical assistance and support
to CMS to efficiently carry out its responsibility of procurement, quality assurance, storage and distribution
of HIV/AIDS related commodities for all government, mission, mine and non-government organizations in
Botswana. The second component will be on provision of technical assistance to the DRU in its mission to
assure quality of ARVs and related commodities used in care and treatment. The third activity supports the
national MASA program in its role to harmonize and coordinate all partners by ensuring the supply chain is
ready to support and sustain the new treatment guidelines and treatment objectives of the program.
In FY2007, SCMS worked with CMS to strengthen management systems through the development of clear
management quality performance indicators and a continuous monitoring and evaluation plan. Additionally,
support improved the IT infrastructure for commodity tracking at the stores and in the procurement and
distribution pipeline. Two key staff at CMS were trained at the SCMS Regional Distribution Center in South
Africa in good warehousing practices plus exchange visits to regional medical stores for benchmarking
purposes. Ten other staff were trained in procurement planning and forecasting at one of the tailor made
SCMS training programs that also covered use of specific software programs: Quantimed for forecasting
and Pipeline for procurement planning. CMS' in house Quality Assurance Unit received in-house training to
ensure quality of ARVs and related commodities that are provided along the supply chain up to the end
user. Other support provided related to the general operations management at the warehouse based on the
findings and recommendations of the Boehringer-Ingelheim Assessment Report that was adopted by
government. SCMS also supported the STI Unit at the MOH by procuring Acyclovir tablets worth $200,000.
DRU received technical assistance to assess registration systems for generic ARVs and training of in-house
staff in dossier review. Evaluation of application dossiers helped clear the back log in the registration
process.
PEPFAR through SCMS supported CMS and other partners in FY2007 to develop national forecasts for
ARVs needs for the next 24 months and set in place a system for continuous updates of these forecasts as
regular activity. In addition, 10 persons were trained in ARV and related commodities forecasting and
procurement planning. Working through the MASA program SCMS supported the setting up and facilitation
of an ARV Working Group that brings together all partners in the sector - MOH, MOLG, CMS, BOTUSA,
MASA, GFATM, Clinton Foundation, ACHAP, Harvard Program and the others for better harmonization of
forecasting and procurement planning. SCMS continues to assist in providing analyzed supply chain
information on both demand and supply sides that can be relied on to make decisions on resource
mobilization and scale up rates.
2008 plans
SCMS working in collaboration with partners will continue to support planned activities helping to further
enhance systems at the national level. Working with CMS, SCMS will provide support for strengthening the
distribution system for ARVs and related commodities including investigating options for a more effective
distribution structure which CMS can adopt to ensure continuous supply in an efficient manner to all the
ART sites (128 clinics under MLG and 32 hospitals under MOH) spread across the whole country. There will
be more focus on building capacity at the treatment site level for the 32 hospitals offering ART and working
with health clinics under the MLG. This work will involve development of tools for inventory management
and transactions tracking; electronic inventory and dispensing records; training of pharmacy staff in
quantification, product requisition; general inventory management training; commodity transactions tracking
information collection and analysis in order to make the supply system be fully pull based.
CMS currently faces huge challenges in projecting demand for ARVs at sites due to unreliable logistic
information flow and hence supporting hospitals and clinics to build capacity for effective supply chain
management will be the major determinant for ensuring a sustainable supply chain needed for HIV
prevention, care and treatment programs. SCMS will provide technical support to the MOH for the
development of a HIV/AIDS commodities tracking system; implementation of a revamped LMIS; train staff in
collection, analysis and use of information; and provide analyzed information to feed into product
forecasting, procurement planning and distribution management (supply and demand management). SCMS
will support the roll out of whatever technological solution is adopted by the MOH that is also in line with the
general health management information systems of the country. SCMS will continue to work with the DRU
to strengthen systems for quality assurance of ARVs in the country's supply chain. The support will include
short term technical assistance for in-house mentoring of DRU staff; training in post marketing surveillance
of ARVs and adoption of technology solution for maintaining the drug register.
GOB is strengthening its activity related to preventive care for HIV positive women. The newly revised care
Activity Narrative: and treatment guidelines recommends annual PAP smear screening for HIV positive women. A PAP smear
screening clinic is being put up for this purpose. Lack of basic equipment is making implementation difficult.
An amount of $80,000 is earmarked for purchase of PAP smear screening equipment so that the clinic
becomes fully operational.
08.T1116
The Botswana National ART Programme is supported by a multidimensional community mobilization
initiative called MASA. The goal of MASA is to ensure universal access to HIV/AIDS treatment care and
services to the citizens of Botswana who require such. The programme is funded and supported by various
partners which include the government, PEPFAR, African Comprehensive HIV/AIDS Partnership (ACHAP).
The MASA ARV Programme currently has over 90,000 patients on HAART in the public and private sectors
and hopes to reach 110,000 patients on HAART by 2009 and 125,000 patients by 2010. These patients will
be served at both the Ministry of Health (MOH) and Ministry of Local Government (MLG) managed sites.
The MOH has established 32 sites which prescribe and dispense ARVs while the MLG has 60 sites
providing ARV prescription and dispensing services and is rolling out to other sites within the system.
For this rapid expansion to be successful, there is need to have a very strong and robust patient
management cum inventory management system deployed at the facilities where ARVs are dispensed.
Patient clinical and dispensing data are currently being managed with two software systems in the
Botswana ART sites - Meditech developed in South Africa and the MASA system developed in Botswana.
The Meditech system is deployed at 4 pilot facilities but as currently deployed, the system is unable to
provide very useful information on patient regimen ratios and inventory management which are crucial for
forecasting and quantification purposes. In addition, it is not available at district clinics. The MASA system is
deployed in most of the other facilities dispensing ARVs. The system has been very useful to the ART
programme for programmatic purposes. However, like the Meditech system, it is unable to provide useful
information on patient regimen ratios and inventory management for quantification purposes. Both programs
need further customization to improve their effectiveness to enable them generate the specific type of
information required for quantification purposes. The two systems are not interfaced making programmatic
data integration and analysis a problem
The challenges faced by the current data capture system for ARVs in the country include poor quantification
capabilities and inadequate tools for data analysis and reporting. This results in poor information flow to
Central Medical Stores (CMS) and MASA thereby affecting quantification of ART resource needs and
management. The CMS and MASA are concerned about these challenges and improving on these
parameters through the use of user friendly software which can be easily customized to the needs of the
Botswana ART programme will make CMS and MASA more responsive to the needs of a rapidly scaling up
programme. CMS currently faces huge challenges in projecting demand for ARVs at sites due to unreliable
logistic information flow and hence supporting hospitals and clinics to build capacity for effective supply
chain management will be the major determinant for ensuring a sustainable supply chain needed for HIV
development of a HIV/AIDS commodities tracking system. This activity will be for support to the national
MASA program in its initiative of developing a Patient Information Management System (PIMS) by
engagement of design consultants to develop the pharmacy module for the PIMS.
08.T1205: SCMS - Laboratory Procurement
In FY 2007 SCMS supported procurement of key reagents, equipment and supplies for USG supported
programs; assessed, recommended and worked with NHL to re-design a more efficient and effective
laboratory supply chain and logistics management system capable of supporting a sustainable prevention,
care and treatment HIV program in the country including a system for specimen and results handling. An
additional activity in 2007 was to review the system for specimen and results handling between site
laboratories and referral laboratories. Physicians at treatment sites have continuously expressed a need to
streamline the system for specimen and results handling which leads at times to multiple same tests being
requested for the same patient with no results coming back from the referral laboratories. Movement of
specimens and results requires almost similar logistical support as moving reagents and other supplies plus
the commodity tracking information and that is why SCMS was asked to help find a solution to this
challenge.
2008 activities will focus more on operationalizing the system across the country, both at the national level
and the testing sites. This will include:
1) Demand forecasting and procurement planning capacity;
2) Inventory management systems at all levels (national coordination and treatment site) consistent with
Good Inventory Management Practices (GIMP);
3) A robust logistics management information system (LMIS) that provides reliable information to feed into
the forecasting and procurement planning plus decision making processes; that supports the management
of laboratory reagents and supplies, this will include supporting NHL to find the right technological solution
that is compatible with general HMIS of the country and help in its roll out to all the laboratories;
4) development and institutionalization of Standard Operating Procedures for managing supplies and key
reagents used in HIV prevention, care and treatment;
5) Training and mentoring of key personnel in the existing laboratories to augment their skills and
capabilities for effective management of laboratory supplies and reagents;
6) Introducing and institutionalizing continuous monitoring and evaluation plan with clear indicators of
performance to measure and using information derived from this process to make improvements in the
supply chain functioning;
7) SCMS will also continue supporting NHL and BOTUSA with procurement of reagents especially for
conducting surveillance and BAIS III (for an estimated amount of $300,000), medical and laboratory
equipments in the interim as NHL strengthens its capacity to undertake all procurement activities at the
country level. Even as NHL takes on this role, SCMS will provide an opportunity for the country to take
advantage of preferential prices that SCMS has negotiated with several manufacturers leveraging its
economies of scale for multiple country procurement potential.